Stephen Ezell

Multi-cancer early detection (MCED) technologies are poised to radically transform the cancer-screening paradigm for the significant benefit of Americans’ individual and public health. Congress can play a critical role in making that transformation happen.

Chinese electric vehicle makers have benefited from aggressive state-sponsored mercantilist policies that have enabled them to produce lower-cost vehicles than foreign competitors can. They should not be allowed to manufacture their products in the United States.

There are many technology policy issues where states have created a patchwork of regulation that impose duplicative costs on businesses, cause confusion for consumers, and act as a drain on the U.S. economy. In order to address these issues, federal preemption would streamline regulation and decrease costs and confusion.

Turning CHIPS Act grants into government equity stakes would undermine their purpose and weaken U.S. efforts to expand domestic semiconductor manufacturing.

Room remains for the Trump administration to better balance the interests of restoring American manufacturing, removing other nations’ unfair trade practices, and orientating like-mined nations to the long-term China threat in the execution of the Trump administration’s trade and tariff policies.

Global Trade and Innovation Policy Alliance (GTIPA) members from 17 countries analyzed how their economies are reacting to U.S. tariffs. Many countries are seeking to support their local producers and establish trade arrangements that are less reliant on the United States.

Small manufacturers power U.S. industry, but many are struggling to compete. Cutting the MEP program would weaken the backbone of America's manufacturing economy.

Universities play a pivotal role in America’s technology economy, serving as a crucial source of research, inventions, patents, start-up technology companies, and regional economic and employment growth. The Bayh-Dole Act has played an instrumental role in spurring academic technology transfer activities that serve as vital drivers of American innovation.

The CHIPS Act tax credit powered America's chip resurgence and letting it expire would stall the momentum.

Imposing blanket tariffs on U.S. semiconductor imports would imperil U.S. leadership across a broad range of digital and nondigital industries while significantly decreasing U.S. economic growth, raising prices, and jeopardizing broader U.S. manufacturing competitiveness.

The Trump administration’s call for “most favored nation” drug price controls will lead to less biopharmaceutical innovation and reduced U.S. drug industry competitiveness. However, the president’s willingness to use tariff negotiations to press other nations to pay their fair share for patented drugs is salutary.

The Trump administration’s “MFN” drug-price proposal would pose a far greater threat to U.S. biopharma innovation than the Inflation Reduction Act, because unlike the IRA’s selective list, MFN could apply across virtually every medicine, multiplying the deleterious impact.

ITIF’s fall seminar course will explore core emerging technologies that are reshaping our world and the public policy challenges and opportunities influencing their development and application. The course is open to congressional and federal staff only.

Join ITIF on Capitol Hill for a timely discussion on how GLP-1 therapies can transform health and economic outcomes—and what policymakers should do to maximize their benefits.

This forum shall explore how Argentina might accelerate growth in its life sciences sector while improving patient access to innovative medicines. It will examine the critical role of strong intellectual property frameworks and efficient regulatory systems in fostering local innovation and promoting local biomanufacturing. We will also explore how university technology transfer can leverage Argentina's established biotechnology expertise to drive sector development and economic growth.

Watch ITIF’s expert panel discussion with leaders from the Council on Global Competitiveness and Innovation (CGCI) and Shield Capital as they examined the vital role Big Tech plays in U.S. technology leadership and national security.

This in-person event on Capitol Hill explored how academic research, entrepreneurship, and public-private partnerships are shaping innovation ecosystems—and what is needed to strengthen them going forward.

Watch now for an expert discussion surrounding the implications of location verification requirements for AI chips.

At the ITIF-KAIST Joint Forum, a distinguished group of experts confronted the turbulence stemming from the Trump administration’s strategic direction and explore critical questions surrounding technology sovereignty. The discussions also focused on practical pathways to strengthen bilateral cooperation between the US and the Republic of Korea (ROK).

Watch now for a summit on Capitol Hill presented by ITIF, Purdue University, and the National Institute for Pharmaceutical Technology and Education (NIPTE) where top leaders in AI, pharmaceutical manufacturing, and public policy will discuss what must be done.

Watch now for an expert panel elucidating the innovation economics of the global semiconductor industry, exploring how the industry is capitalized, and exploring the landscape of global semiconductor competition and policy in the year ahead.

Watch now for a conversation detailing the effect and importance of Manufacturing USA, and emphasizing the importance of sustained investment in the program to policymakers.

Please join the Information Technology and Innovation Foundation for an expert briefing event to discuss the findings of a 20-month ITIF investigation into Chinese firms’ innovative capabilities in key advanced industries, including robotics, chemicals, nuclear power, electric vehicles, semiconductors, AI, quantum computing, and biotechnology.

Stephen Ezell joined an expert panel hosted by The Hill to discuss how nuclear power can help the United States meet unprecedented electricity demand and examine the path ahead after the ADVANCE Act.